Moderna on AWS
Founded in 2010, Moderna, Inc. is a biotechnology company pioneering a new class of messenger RNA (mRNA) medicines. Moderna has selected AWS as its preferred cloud provider, as well as its standard for analytics and machine learning workloads.
Moderna has steadily transformed from a discovery-stage biotech company into a commercial-stage biopharma enterprise, developing a diverse portfolio of mRNA-based vaccines and therapeutics—and Amazon Web Services (AWS) has been its trusted cloud services provider throughout the journey. Moderna uses a broad range of AWS services to support every aspect of its digital, data-driven operations, with the goal of reducing the time and cost of bringing new life-saving therapies to market. Moderna has demonstrated the power of its cloud-based strategy in the speed with which it delivered its highly effective COVID-19 vaccine and its capacity to scale production globally. From leveraging on-demand compute power and machine learning (ML) to accelerate discovery and development, to building flexible capacity and real-time analytics into its award-winning, cloud-native manufacturing facility, Moderna leverages the scale, reliability, and performance of AWS to expand the possibilities of its mRNA platform and create a new generation of medicines.
AWS Powers Moderna’s Digital Biotechnology Platform to Develop a New Class of Vaccines and Therapeutics
In a pandemic, speed to market matters and Moderna was able to complete the sequence for its mRNA COVID-19 vaccine in just 2 days using machine learning built on AWS. The first clinical batch was released just 25 days later. Artificial intelligence (AI) algorithms enable drug development from rapid experimentation cycles to help design mRNA and DNA sequences to the automation of quality control analyses, saving hours of manual review of improvements across production processes and logistics. mRNA science has applicability beyond just one application, and Moderna is rapidly expanding into other infectious disease targets and modalities like oncology and autoimmune disease—using the flexible, programmable nature of mRNA, powered by machine learning, to revolutionize how diseases are treated.
The science behind mRNA medicines is advancing at a rapid pace, and building Moderna’s technology platform on AWS gives our scientists the insights, agility, and security they need to continue to lead in the industry.”
Chief Executive Officer, Moderna
Accelerating COVID-19 Vaccine Development with Marcello Damiani, Chief Digital and Operational Excellence Officer at Moderna
Marcello Damiani, chief digital and operational excellence officer at Moderna, joins Todd Weatherby, vice president of AWS Professional Services Worldwide, for a discussion on developing Moderna’s COVID-19 vaccine, scaling systems to enable global distribution, and leveraging cloud technologies to accelerate processes. Moderna is pioneering a new class of medicines made of mRNA, which holds significant potential to improve the lives of patients.
Moderna Therapeutics Delivers mRNA Drugs Faster, at Lower Cost Using AWS
Moderna was founded over a decade ago with the goal of delivering on the promise of mRNA science to create novel medicines for unmet patient needs. The company's therapeutic areas include infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. As of February 2021, Moderna's pipeline includes 24 development programs, with 13 having entered clinical studies.
Moderna Achieves Speed and Scale by Using AWS
Dave Johnson, PhD, chief data and artificial intelligence (AI) officer at Moderna, discusses how building on AWS is helping the company achieve its goal of revolutionizing the way diseases are treated with mRNA therapy by providing speed, scale, and insights that can drive the business forward.
Modernizing Pharmaceutical Manufacturing with IoT and AI/ML at Moderna
Moderna, a “born in the cloud” pharma company, used AWS Internet of Things (IoT), AI/ML, and data analytics services to build a connected, intelligent biopharmaceutical manufacturing and supply chain environment. Moderna constructed a 200,000-square-foot Good Manufacturing Practices (GMP)–compliant manufacturing facility utilizing SAP S/4HANA and AWS services to facilitate a “batch of one,” resulting in an ISPE Facility of the Future Award.
Data Empowers Patients and Providers